Target intelligence / Profile preview

Multiple growth factor, cytokine, and adhesion molecule receptors

Molecular classification
Receptor, Growth factor receptor, Cytokine receptor, Cell adhesion molecule
01

Overview

The term Multiple growth factor, cytokine, and adhesion molecule receptors does not refer to a single molecular entity but rather a broad functional grouping of cell surface proteins involved in intercellular communication and environmental sensing. Growth factor receptors, such as VEGFR and EGFR, are primary regulators of cell growth and survival, while cytokine receptors mediate the complex signaling of the immune system (National Cancer Institute [NCI], 2023). Adhesion molecules, including integrins and selectins, are essential for maintaining tissue architecture and facilitating the migration of immune cells to sites of injury or infection (Nature Education, 2014). In therapeutic contexts, this classification is frequently used to describe the activity of multi-kinase inhibitors or broad-spectrum immunomodulators that target several overlapping pathways to treat complex diseases like metastatic cancer or chronic inflammatory disorders (PubMed, 2021). Because these receptors often share downstream signaling cascades, such as the MAPK or PI3K/Akt pathways, targeting them collectively can help overcome cellular redundancy and drug resistance (StatPearls, 2023).

Other names
Growth factor receptorsCytokine receptorsCell adhesion moleculesMulti-receptor targets
02

Mechanism of action

Simultaneous inhibition of multiple signaling pathways by targeting various receptor tyrosine kinases, cytokine-binding domains, or cell-surface attachment proteins.

03

Biological functions

Signal transductionCell proliferationImmune responseCell adhesionAngiogenesisApoptosis
04

Disease associations

CancerInflammationAutoimmune diseaseCardiovascular diseaseFibrosis
05

Safety considerations

Systemic toxicity due to broad pathway inhibitionOff-target effectsHypertensionImpaired wound healingCytopenia
06

Interacting drugs

Sorafenib

5 more in the full profile.

07

Biomarkers

VEGF levelsCirculating cytokines (e.g., IL-6, TNF-alpha)Soluble adhesion molecules (e.g., sICAM-1)Phosphorylation status of downstream effectors (e.g., STAT3, ERK)

Beyond the preview

Go deeper on Multiple growth factor, cytokine, and adhesion molecule receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple growth factor, cytokine, and adhesion molecule receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call